Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan Jones

Showing results (231-240 of 278) with videos related to

Pageof 28
Sort By:
Frontiers in Oncology|October 2, 2023
Impact of circulating lymphoma cells at diagnosis on outcomes in patients with Waldenstrom macroglobulinemiaAnsel Nalin, Qiuhong Zhao, Timothy Voorhees, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|May 5, 2012
Neutron radiotherapy in South Africa: neutron radiotherapy should continueWolfgang Sauerwein, Rita Engenhart-Cabillic, Jeffrey D Forman, et al.
Studies in Health Technology and Informatics|April 6, 2016
Virtual Airway Skills Trainer (VAST) SimulatorDoga Demirel, Alexander Yu, Tansel Halic, et al.
Blood|June 17, 2004
Long-term survival benefit and improved complete cytogenetic and molecular response rates with imatinib mesylate in Philadelphia chromosome-positive chronic-phase chronic myeloid leukemia after failure of interferon-alphaHagop M Kantarjian, Jorge E Cortes, Susan O'Brien, et al.
Blood|December 16, 2010
Results of allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia patients who failed tyrosine kinase inhibitors after developing BCR-ABL1 kinase domain mutationsElias Jabbour, Jorge Cortes, Fabio P S Santos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2008
Effective treatment of acute promyelocytic leukemia with all-trans-retinoic acid, arsenic trioxide, and gemtuzumab ozogamicinFarhad Ravandi, Eli Estey, Dan Jones, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 23, 2025
Resistance Mechanism for Zanubrutinib in Marginal Zone LymphomaJohn Sharp, Arwa Y Shana'ah, Timothy J Voorhees, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 7, 2009
Phase II study of alemtuzumab in combination with pentostatin in patients with T-cell neoplasmsFarhad Ravandi, Ahmed Aribi, Susan O'Brien, et al.
The Journal of Molecular Diagnostics : JMD|October 17, 2021
Electronic Health Records and Genomics: Perspectives from the Association for Molecular Pathology Electronic Health Record (EHR) Interoperability for Clinical Genomics Data Working GroupAlexis B Carter, Lynne V Abruzzo, Julie W Hirschhorn, et al.
The Journal of Molecular Diagnostics : JMD|August 11, 2007
Identification and validation of biomarkers of IgV(H) mutation status in chronic lymphocytic leukemia using microfluidics quantitative real-time polymerase chain reaction technologyLynne V Abruzzo, Lynn L Barron, Keith Anderson, et al.
Pageof 28

Showing results (231-240 of 278) with videos related to

Sort By:
Pageof 28
Frontiers in Oncology|October 2, 2023
Impact of circulating lymphoma cells at diagnosis on outcomes in patients with Waldenstrom macroglobulinemiaAnsel Nalin, Qiuhong Zhao, Timothy Voorhees, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|May 5, 2012
Neutron radiotherapy in South Africa: neutron radiotherapy should continueWolfgang Sauerwein, Rita Engenhart-Cabillic, Jeffrey D Forman, et al.
Studies in Health Technology and Informatics|April 6, 2016
Virtual Airway Skills Trainer (VAST) SimulatorDoga Demirel, Alexander Yu, Tansel Halic, et al.
Blood|June 17, 2004
Long-term survival benefit and improved complete cytogenetic and molecular response rates with imatinib mesylate in Philadelphia chromosome-positive chronic-phase chronic myeloid leukemia after failure of interferon-alphaHagop M Kantarjian, Jorge E Cortes, Susan O'Brien, et al.
Blood|December 16, 2010
Results of allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia patients who failed tyrosine kinase inhibitors after developing BCR-ABL1 kinase domain mutationsElias Jabbour, Jorge Cortes, Fabio P S Santos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2008
Effective treatment of acute promyelocytic leukemia with all-trans-retinoic acid, arsenic trioxide, and gemtuzumab ozogamicinFarhad Ravandi, Eli Estey, Dan Jones, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 23, 2025
Resistance Mechanism for Zanubrutinib in Marginal Zone LymphomaJohn Sharp, Arwa Y Shana'ah, Timothy J Voorhees, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 7, 2009
Phase II study of alemtuzumab in combination with pentostatin in patients with T-cell neoplasmsFarhad Ravandi, Ahmed Aribi, Susan O'Brien, et al.
The Journal of Molecular Diagnostics : JMD|October 17, 2021
Electronic Health Records and Genomics: Perspectives from the Association for Molecular Pathology Electronic Health Record (EHR) Interoperability for Clinical Genomics Data Working GroupAlexis B Carter, Lynne V Abruzzo, Julie W Hirschhorn, et al.
The Journal of Molecular Diagnostics : JMD|August 11, 2007
Identification and validation of biomarkers of IgV(H) mutation status in chronic lymphocytic leukemia using microfluidics quantitative real-time polymerase chain reaction technologyLynne V Abruzzo, Lynn L Barron, Keith Anderson, et al.
Pageof 28